Skip to main content

Table 1 List of graphene oxide and reduced graphene oxide composites and their drug and gene delivery applications

From: Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers

Composite

Drug Type

Delivery Stimulus

Target Cell

Applications

Study Type

Additional Functions

Ref

rGO-MPAH-FA

pDNA

NIR

HEK-293A

Gene therapy

In vitro

-

[114]

BPBA@GA-rGO

GA

pH

A549

Chemotherapeutic

In vitro

-

[150]

rGO/KGN@Ge

KGN

-

ADSC

Repairing cartilage defect

In vitro

-

[151]

rGO/CS

5-FU

CUR

-

HT-29

Chemotherapy

In vitro

-

[152]

rGO@MSN

DOX

pH

A549

Cancer therapy

In vitro

Phototherapy

[153]

rGO/β-carotene

Nrf2

-

Hepatic stellate cells

Ameliorate hepatic fibrosis and influences Nrf2 signaling

In vivo

-

[154]

MrGO-AA-g-4-HC

CPT

4-HC

pH

MCF7

WS1

Chemo-photodynamic therapy

Cancer therapy

In vitro/

In vivo

Phototherapy

[141]

PEG-BPEI-rGO

DOX

NIR

PC-3

Cancer treatment

In vitro

Phototherapy

[149]

CHA-rGO

DOX

-

KB epidermal

carcinoma

Cancer treatment

In vitro/

In vivo

-

[144]

rGO/β-CD

Azo-C60

UV

PC-12

Protection cytotoxicity from nitric oxide

In vitro

-

[155]

rGO/MSN/PDA

DOX

pH

NIR

MHCC97-L

MHCC97-H

Chemo-photothermal therapy

In vitro

Phototherapy

[156]

rGO-PDA

Ara

NIR

HeLa

Antitumor therapy

In vitro/

In vivo

Phototherapy

[157]

rGO-PLPEG

siRNA

-

MCF7

Gene therapy

In vitro

-

[158]

CUR@HSA-MNPs@rGO

DOX

pH

SH-SY5Y

Cancer treatment

In vitro

-

[145]

rGO/HA-SP

DOX

-

MDCK

A549

Cellular imaging

Cancer treatment

In vitro/

In vivo

Bioimaging

[33]

PEG-rGO

ssRNA

-

HeLa

Gene therapy

In vitro

-

[17]

Zn-dopamine-rGO

DOX

pH

T-47D

MCF10A

Cancer treatment

Antibacterial

In vitro

Antibacterial

[159]

Gd-rGO

5-FU

-

H1299

Optical coherence tomography

Magnetic resonance imaging

In vitro

Bioimaging

[160]

(CA-BODIPY)-PPDN/rGO

DOX

pH

Thermal

MDCK

MDA-MB-231

Cellular imaging

Cancer treatment

In vitro

Bioimaging

[161]

CuS(DOX)-GO-HA

DOX

pH

NIR

SCC-7

MDA-MB-231

BT-474

Cancer therapy

In vitro/

In vivo

Phototherapy

[146]

GO-PEG

DOX

pH

CAL-27

SCC-25

HOK

Cancer therapy

In vitro

-

[147]

GO@Ge

PAC

pH

L929

MCF7

Chemo-photothermal therapy

In vitro

Phototherapy

[148]

MGO-PEG-CET

DOX

pH

CT26

Chemo-phototherapy

In vitro/

In vivo

Phototherapy

[162]

GO/Red blood cell membrane

DOX

pH

MCF7

Cancer chemotherapy

In vitro/

In vivo

-

[163]

GO/Fe3O4

MTX

-

Caov-4

HeLa

MCF7

Cancer chemotherapy

In vitro

-

[164]

GO/Au-PEG-PLA

miR-101

NIR

MCF7

MDA

HU02

Gene therapy

In vitro

Phototherapy

[165]

GO-PEG-PLA

miR-101

NIR

MCF7

MCF10A

MDA-MB-231

HU02

Chemo-photothermal therapy

In vitro

Phototherapy

[166]

  1. Abbreviations: 4-HC 4-hydroxy coumarin, 5-FU 5-Fluorouracil, AA Allylamine, Ara Cytarabine hydrochloride, Au Gold, Azo-C60 Azobenzene-functionalized fullerene, BODIPY Boron-dipyrromethene, BPBA Biotin-adorned poly-(ethylene oxide)bis-(amine), BPEI Branched polyethylenimine, CA Catechol, CD Cyclodextrin, CET Cetuximab, CHA Cholesteryl hyaluronic acid, CPT Camptothecin, CS Chitosan, CUR Curcumin, CuS Copper sulfide, DOX Doxorubicin, FA Folic acid, Fe3O4 Iron oxide, GA Gallic acid, Gd Gadolinium, Ge Gelatin, GO Graphene oxide, HA Hyaluronic acid, HC Hydroxycoumarin, HSA Human serum albumin, KGN Kartogenin, MGO Magnetic graphene oxide, MNPs Magnetic nanoparticles, MPAH Modified poly(allylamine hydrochloride), MrGO Magnetic reduced graphene oxide, MSN Mesoporous silica nanoparticle, MTX Methotrexate, NIR Near-infrared, Nrf2 Nuclear factor erythroid 2-related factor-2, PAC Paclitaxel, PAH Polyallylamine hydrochloride, PDA Polydopamine, pDNA Plasmid DNA, PEG Polyethylene glycol, PET Positron emission tomography, PLA Poly-L-arginine, PLPEG Phospholipid-PEG, PPDN PEG–g–poly (DMA–co–NIPAAm), R8 Octaarginine, rGO Reduced graphene oxide, SP Spiropyran, Zn Zinc